Opinion: Americans think the government should regulate profits from Covid-19 treatments. Be careful what you wish for
As the death toll from the novel coronavirus climbs toward 90,000, a new national survey shows that a majority of Americans believe that the U.S. government should regulate the profits drug companies can make from drugs that treat or prevent Covid-19.
Although the pharmaceutical industry’s pricing practices have come under increasing scrutiny in the past few years, Covid-19 seems to be galvanizing public opinion in a way that should make any drug company executive or investor who is imagining fat profits for its Covid-19 therapies of vaccines think again.
